Related Experiment Video
Updated: Mar 6, 2026

Acquisition of Resting-State Functional Magnetic Resonance Imaging Data in the Rat
Published on: August 28, 2021
Intranasal Dexmedetomidine for Procedural Sedation in Children, a Suitable Alternative to Chloral Hydrate
Giorgio Cozzi1, Stefania Norbedo2, Egidio Barbi2
1Emergency Department, Institute for Maternal and Child Health IRCCS "Burlo Garofolo", via dell'Istria 65/1, 34132, Trieste, Italy. giorgiocozzi@gmail.com.
Insights
Chloral hydrate, a common sedative for children, is now banned in some countries due to safety concerns. Intranasal dexmedetomidine offers a safer and equally effective alternative for pediatric procedural sedation.
Area of Science:
- Pediatric Sedation
- Pharmacology
- Anesthesiology
Background:
- Chloral hydrate has been a widely used sedative for pediatric diagnostic procedures for decades.
- Recent bans in Italy and France highlight concerns regarding chloral hydrate's carcinogenicity and genotoxicity.
- Dexmedetomidine is an emerging sedative with a favorable safety profile for pediatric procedural sedation.
Purpose of the Study:
- To evaluate intranasal dexmedetomidine as a safer alternative to chloral hydrate for pediatric procedural sedation.
- To compare the efficacy and safety of intranasal dexmedetomidine with chloral hydrate in children undergoing non-painful procedures.
Main Methods:
- Review of studies comparing intranasal dexmedetomidine and chloral hydrate for pediatric procedural sedation.
- Analysis of efficacy and safety data, including impact on respiratory drive and airway patency.
Main Results:
- Dexmedetomidine demonstrates efficacy and safety in pediatric procedural sedation.
- Intranasal administration of dexmedetomidine is associated with satisfactory procedural success rates.
- Comparative studies indicate dexmedetomidine is as effective and safer than chloral hydrate for non-painful procedures in children.
Conclusions:
- Intranasal dexmedetomidine presents a viable and safer alternative to chloral hydrate for pediatric procedural sedation.
- The unique properties of dexmedetomidine, including minimal impact on respiratory function, support its use.
- Regulatory actions against chloral hydrate further support the adoption of dexmedetomidine in pediatric practice.
Abstract:
Sedation is often required for children undergoing diagnostic procedures. Chloral hydrate has been one of the sedative drugs most used in children over the last 3 decades, with supporting evidence for its efficacy and safety. Recently, chloral hydrate was banned in Italy and France, in consideration of evidence of its carcinogenicity and genotoxicity. Dexmedetomidine is a sedative with unique properties that has been increasingly used for procedural sedation in children. Several studies demonstrated its efficacy and safety for sedation in non-painful diagnostic procedures. Dexmedetomidine's impact on respiratory drive and airway patency and tone is much less when compared to the majority of other sedative agents. Administration via the intranasal route allows satisfactory procedural success rates. Studies that specifically compared intranasal dexmedetomidine and chloral hydrate for children undergoing non-painful procedures showed that dexmedetomidine was as effective as and safer than chloral hydrate. For these reasons, we suggest that intranasal dexmedetomidine could be a suitable alternative to chloral hydrate.
Related Concept Videos
Parenteral Anesthetics: Overview
Inhalational Anesthetics: Overview
Skeletal Muscle Relaxants: Therapeutic Uses
Stages of General Anesthesia
Depolarizing Blockers: Pharmocokinetics
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

